OAM
Oppenheimer Asset Management’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.1M | Buy |
493,724
+23,159
| +5% | +$1.6M | 0.39% | 56 |
|
|
2025
Q1 | $32.7M | Buy |
470,565
+69,545
| +17% | +$4.83M | 0.41% | 55 |
|
|
2024
Q4 | $34.5M | Buy |
401,020
+7,786
| +2% | +$670K | 0.42% | 49 |
|
|
2024
Q3 | $46.8M | Buy |
393,234
+3,758
| +1% | +$447K | 0.56% | 35 |
|
|
2024
Q2 | $55.6M | Buy |
389,476
+44,981
| +13% | +$6.42M | 0.71% | 20 |
|
|
2024
Q1 | $44.2M | Sell |
344,495
-57,561
| -14% | -$7.39M | 0.65% | 28 |
|
|
2023
Q4 | $41.6M | Buy |
402,056
+6,808
| +2% | +$704K | 0.58% | 37 |
|
|
2023
Q3 | $35.9M | Buy |
395,248
+239,042
| +153% | +$21.7M | 0.55% | 39 |
|
|
2023
Q2 | $25.3M | Sell |
156,206
-5,811
| -4% | -$940K | 0.37% | 56 |
|
|
2023
Q1 | $25.8M | Sell |
162,017
-53,705
| -25% | -$8.55M | 0.4% | 55 |
|
|
2022
Q4 | $29.2M | Sell |
215,722
-17,447
| -7% | -$2.36M | 0.47% | 46 |
|
|
2022
Q3 | $23.2M | Buy |
233,169
+6,043
| +3% | +$602K | 0.41% | 54 |
|
|
2022
Q2 | $25.3M | Sell |
227,126
-9,191
| -4% | -$1.02M | 0.42% | 52 |
|
|
2022
Q1 | $26.2M | Buy |
236,317
+2,248
| +1% | +$250K | 0.37% | 59 |
|
|
2021
Q4 | $26.2M | Buy |
234,069
+2,876
| +1% | +$322K | 0.35% | 59 |
|
|
2021
Q3 | $22.2M | Sell |
231,193
-66,765
| -22% | -$6.41M | 0.32% | 70 |
|
|
2021
Q2 | $25M | Buy |
297,958
+66
| +0% | +$5.53K | 0.36% | 59 |
|
|
2021
Q1 | $20.1M | Buy |
297,892
+28,539
| +11% | +$1.92M | 0.31% | 67 |
|
|
2020
Q4 | $18.8M | Buy |
269,353
+16,572
| +7% | +$1.16M | 0.31% | 70 |
|
|
2020
Q3 | $17.6M | Buy |
252,781
+16,205
| +7% | +$1.13M | 0.34% | 62 |
|
|
2020
Q2 | $15.5M | Sell |
236,576
-16,745
| -7% | -$1.1M | 0.32% | 70 |
|
|
2020
Q1 | $15.3M | Buy |
253,321
+23,698
| +10% | +$1.43M | 0.37% | 62 |
|
|
2019
Q4 | $13.3M | Buy |
229,623
+9,187
| +4% | +$532K | 0.28% | 81 |
|
|
2019
Q3 | $11.4M | Buy |
220,436
+19,339
| +10% | +$1,000K | 0.25% | 90 |
|
|
2019
Q2 | $10.3M | Buy |
201,097
+22,500
| +13% | +$1.15M | 0.23% | 100 |
|
|
2019
Q1 | $9.34M | Buy |
178,597
+22,809
| +15% | +$1.19M | 0.21% | 122 |
|
|
2018
Q4 | $7.18M | Buy |
155,788
+7,006
| +5% | +$323K | 0.18% | 133 |
|
|
2018
Q3 | $7.01M | Buy |
148,782
+39,049
| +36% | +$1.84M | 0.16% | 163 |
|
|
2018
Q2 | $5.06M | Buy |
109,733
+8,325
| +8% | +$384K | 0.12% | 206 |
|
|
2018
Q1 | $5M | Buy |
101,408
+30,764
| +44% | +$1.52M | 0.13% | 205 |
|
|
2017
Q4 | $3.4M | Hold |
70,644
| – | – | 0.09% | 266 |
|
|
2017
Q3 | $3.4M | Buy |
70,644
+17,805
| +34% | +$857K | 0.09% | 268 |
|
|
2017
Q2 | $2.27M | Buy |
52,839
+12,033
| +29% | +$516K | 0.06% | 329 |
|
|
2017
Q1 | $1.4M | Buy |
+40,806
| New | +$1.4M | 0.04% | 454 |
|